G protein-mediated inhibition of Cav3.2 T-type channels revisited

Molecular Pharmacology

Volumn 77, Issue 2, 2010, Pages 136-138

  Perez Reyes, Edward ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BISINDOLYLMALEIMIDE; CALCIUM CHANNEL CAV 3.2; CALCIUM CHANNEL T TYPE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROKININ 1 RECEPTOR; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

CHANNEL GATING; ENZYME ACTIVATION; HUMAN; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTISTIC DISORDER; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; EPILEPSY; GTP-BINDING PROTEINS; HUMANS; MUTATION;

EID: 74549121505     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.062133     Document Type: Review

References (16)

1. 2 subunits. Proc Natl Acad Sci U S A 103:14590-14595.
2. 1 receptor in rat adrenal glomerulosa cells: requirement of the combined action of the G βγ protein subunit and cyclic adenosine 3′,5′-monophosphate. Mol Endocrinol 11:503-514.
3. Godfraind T, Miller R, and Wibo M (1986) Calcium antagonism and calcium entry blockade. Pharmacol Rev 38:321-416.
4. Hu C, Depuy SD, Yao J, McIntire WE, and Barrett PQ (2009) Protein kinase A activity controls the regulation of T-type Cav3.2 channels by Gβγ dimers. J Biol Chem 284:7465-7473.
5. Huc S, Monteil A, Bidaud I, Barbara G, Chemin J, and Lory P (2009) Regulation of T-type calcium channels: signalling pathways and functional implications. Biochim Biophys Acta 1793:947-952.
6. Iftinca MC and Zamponi GW (2009) Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci 30:32-40.
7. q/11 and Gβγ. J Neurosci 20:5623-5629.
8. McGivern JG (2006) Pharmacology and drug discovery for T-type calcium channels. CNS Neurol Disord Drug Targets 5:587-603.
9. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther 328:621-627.
10. v3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy. J Neurosci 29:371-380.
11. V3.2 channels by neurokinin 1 receptors. Mol Pharmacol 78:202-210.
12. Schroeder JE, Fischbach PS, and McCleskey EW (1990) T-type calcium channels: heterogeneous expression in rat sensory neurons and selective modulation by phorbol esters. J Neurosci 10:947-951.
13. v3.2 T-type calcium channels. Mol Pharmacol 73:1596-1609.
14. Uebele VN, Gotter AL, Nuss CE, Kraus RL, Doran SM, Garson SL, Reiss DR, Li Y, Barrow JC, Reger TS, et al. (2009) Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice. J Clin Invest 119:1659-1667.
15. Wolfe JT, Wang H, Howard J, Garrison JC, and Barrett PQ (2003) T-type calcium channel regulation by specific G-protein βγ subunits. Nature 424:209-213.
16. Zhong X, Liu JR, Kyle JW, Hanck DA, and Agnew WS (2006) A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum Mol Gen 15:1497-1512.